{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:32:40Z","timestamp":1777084360631,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004382","name":"Polish Academy of Sciences Krak\u00f3w","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pharep.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T13:17:24Z","timestamp":1429967844000},"page":"1178-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study"],"prefix":"10.1007","volume":"67","author":[{"given":"Agnieszka","family":"Basi\u0144ska-Ziobro\u0144","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W\u0142adys\u0142awa A.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"W\u00f3jcikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.04.005_bib0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0110","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1185\/030079904X12708","article-title":"Focus on levomepromazine","volume":"20","author":"Green","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharep.2015.04.005_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-684X-12-2","article-title":"Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review","volume":"12","author":"Dietz","year":"2013","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.pharep.2015.04.005_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2014.05.005","article-title":"The cytochrome P450-catalyzed metabolism of levomepromazine, a phenothiazine neuroleptic with a wide spectrum of clinical application","volume":"90","author":"W\u00f3jcikowski","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0125","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.pharep.2014.07.012","article-title":"The influence of amitriptyline and carbamazepine on levomepromazine metabolism in human liver: an in vitro study","volume":"66","author":"W\u00f3jcikowski","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2015.04.005_bib0130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2125.1990.tb03827.x","article-title":"The effects of \u03b2-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine","volume":"30","author":"Kallio","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0135","first-page":"89","article-title":"Inhibitory effects of neuroleptics on debrisoquine oxidation in man","volume":"22","author":"Syv\u00e4lahti","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00228-009-0640-9","article-title":"O-demethylation of codeine to morphine inhibited by low-dose levomepromazine","volume":"65","author":"Vevelstad","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/792456","article-title":"Comparative cytochrome P450 in vitro inhibition by atypical antipsychotic drugs","author":"Gervasini","year":"2013","journal-title":"ISRM Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0150","first-page":"1055","article-title":"Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes","volume":"55","author":"Daniel","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0378-4347(93)80065-C","article-title":"High-performance liquid chromatographic method for the routine determination of diclofenac and its hydroxyl and methoxy metabolites from in vitro systems","volume":"620","author":"Schmitz","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.pharep.2015.04.005_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0924-977X(03)00105-6","article-title":"The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes","volume":"14","author":"W\u00f3jcikowski","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0165","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1124\/dmd.30.9.970","article-title":"Catalytic specificity of CYP2D isoforms in rat and human","volume":"30","author":"Hiroi","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2015.04.005_bib0170","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1734-1140(12)70938-6","article-title":"Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver","volume":"64","author":"W\u00f3jcikowski","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2015.04.005_bib0175","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/clinchem\/24.10.1828","article-title":"Distribution of thioridazine and its metabolites in human tissues and fluids obtained postmortem","volume":"24","author":"Dinovo","year":"1978","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharep.2015.04.005_bib0180","first-page":"449","article-title":"Distribution interactions between perazine and antidepressant drugs. In vivo studies","volume":"52","author":"W\u00f3jcikowski","year":"2000","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.legalmed.2006.09.001","article-title":"A fatal case of amoxapine poisoning under the influence of chronic use of psychotropic drugs","volume":"9","author":"Kudo","year":"2007","journal-title":"Leg Med"},{"key":"10.1016\/j.pharep.2015.04.005_bib0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/j.1875-9114.1981.tb02538.x","article-title":"Amoxapine-an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy","volume":"1","author":"Lydiard","year":"1981","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharep.2015.04.005_bib0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.euroneuro.2004.05.008","article-title":"Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms","volume":"15","author":"Daniel","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2015.04.005_bib0200","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/0006-2952(89)90433-4","article-title":"The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man","volume":"38","author":"Kobayashi","year":"1989","journal-title":"Biochem Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:03Z","timestamp":1752611763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.04.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1734114015000742"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.005","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}